$XLRN Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in ACCELERON PHARMA INC.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of all insider trading transactions in ACCELERON PHARMA INC. Get notifications about new insider transactions in ACCELERON PHARMA INC for free.

Page:   < prev 1 2 3 4 5 6 ... 11 next >

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jul 06 2020XLRNACCELERON PHARMA I ...Dable Habib JCEO and PresidentSellS95.8513,0471,250,555119,577132.6 K to 119.6 K (-9.84 %)
Jul 06 2020XLRNACCELERON PHARMA I ...Dable Habib JCEO and PresidentSellS94.463,000283,380132,624135.6 K to 132.6 K (-2.21 %)
Jul 06 2020XLRNACCELERON PHARMA I ...Dable Habib JCEO and PresidentSellS93.533,700346,061135,624139.3 K to 135.6 K (-2.66 %)
Jul 06 2020XLRNACCELERON PHARMA I ...Dable Habib JCEO and PresidentBuyM35.0450,0001,752,000139,32489.3 K to 139.3 K (+55.98 %)
Jul 06 2020XLRNACCELERON PHARMA I ...CELGENE CORP /DE/10% OwnerBuyP92.50108,1089,999,9906,971,7726.9 M to 7 M (+1.58 %)
Jun 05 2020XLRNACCELERON PHARMA I ...Hite ChristopherDirectorOption ExerciseA92.0910,267945,48810,267
Jun 05 2020XLRNACCELERON PHARMA I ...Hite ChristopherDirectorOption ExerciseA92.0910,267945,48810,267
Apr 10 2020XLRNACCELERON PHARMA I ...Veness Adam MSVP, General Counse ...Option ExerciseM27.976,000167,8200
Apr 10 2020XLRNACCELERON PHARMA I ...Veness Adam MSVP, General Counse ...SellS87.5341736,50021,16121.6 K to 21.2 K (-1.93 %)
Apr 10 2020XLRNACCELERON PHARMA I ...Veness Adam MSVP, General Counse ...SellS86.691,10095,35921,57822.7 K to 21.6 K (-4.85 %)
Apr 10 2020XLRNACCELERON PHARMA I ...Veness Adam MSVP, General Counse ...SellS85.772,883247,27522,67825.6 K to 22.7 K (-11.28 %)
Apr 10 2020XLRNACCELERON PHARMA I ...Veness Adam MSVP, General Counse ...SellS84.6270059,23425,56126.3 K to 25.6 K (-2.67 %)
Apr 10 2020XLRNACCELERON PHARMA I ...Veness Adam MSVP, General Counse ...SellS83.4990075,14126,26127.2 K to 26.3 K (-3.31 %)
Apr 10 2020XLRNACCELERON PHARMA I ...Veness Adam MSVP, General Counse ...BuyM27.976,000167,82027,16121.2 K to 27.2 K (+28.35 %)
Apr 10 2020XLRNACCELERON PHARMA I ...MCLAUGHLIN KEVIN FSVP, CFO and Treasu ...Option ExerciseM41.2017,226709,71111,000
Apr 10 2020XLRNACCELERON PHARMA I ...MCLAUGHLIN KEVIN FSVP, CFO and Treasu ...Option ExerciseM30.1710,000301,70031,300
Apr 10 2020XLRNACCELERON PHARMA I ...MCLAUGHLIN KEVIN FSVP, CFO and Treasu ...Option ExerciseM27.9710,000279,7008,300
Apr 10 2020XLRNACCELERON PHARMA I ...MCLAUGHLIN KEVIN FSVP, CFO and Treasu ...Option ExerciseM41.2012,774526,28928,226
Apr 10 2020XLRNACCELERON PHARMA I ...MCLAUGHLIN KEVIN FSVP, CFO and Treasu ...Option ExerciseM24.114,00096,4400
Apr 10 2020XLRNACCELERON PHARMA I ...MCLAUGHLIN KEVIN FSVP, CFO and Treasu ...SellS88.1917,2261,519,16111,21628.4 K to 11.2 K (-60.57 %)
Apr 10 2020XLRNACCELERON PHARMA I ...MCLAUGHLIN KEVIN FSVP, CFO and Treasu ...BuyM41.2017,226709,71128,44211.2 K to 28.4 K (+153.58 %)
Apr 10 2020XLRNACCELERON PHARMA I ...MCLAUGHLIN KEVIN FSVP, CFO and Treasu ...SellS87.503,703324,01311,21614.9 K to 11.2 K (-24.82 %)
Apr 10 2020XLRNACCELERON PHARMA I ...MCLAUGHLIN KEVIN FSVP, CFO and Treasu ...SellS86.795,921513,88414,91920.8 K to 14.9 K (-28.41 %)
Apr 10 2020XLRNACCELERON PHARMA I ...MCLAUGHLIN KEVIN FSVP, CFO and Treasu ...SellS85.8015,4101,322,17820,84036.3 K to 20.8 K (-42.51 %)
Apr 10 2020XLRNACCELERON PHARMA I ...MCLAUGHLIN KEVIN FSVP, CFO and Treasu ...SellS84.893,803322,83736,25040.1 K to 36.3 K (-9.49 %)
Apr 10 2020XLRNACCELERON PHARMA I ...MCLAUGHLIN KEVIN FSVP, CFO and Treasu ...SellS83.685,037421,49640,05345.1 K to 40.1 K (-11.17 %)
Apr 10 2020XLRNACCELERON PHARMA I ...MCLAUGHLIN KEVIN FSVP, CFO and Treasu ...SellS82.832,900240,20745,09048 K to 45.1 K (-6.04 %)
Apr 10 2020XLRNACCELERON PHARMA I ...MCLAUGHLIN KEVIN FSVP, CFO and Treasu ...BuyM30.1710,000301,70047,99038 K to 48 K (+26.32 %)
Apr 10 2020XLRNACCELERON PHARMA I ...MCLAUGHLIN KEVIN FSVP, CFO and Treasu ...BuyM27.9710,000279,70037,99028 K to 38 K (+35.73 %)
Apr 10 2020XLRNACCELERON PHARMA I ...MCLAUGHLIN KEVIN FSVP, CFO and Treasu ...BuyM41.2012,774526,28927,99015.2 K to 28 K (+83.95 %)
Apr 10 2020XLRNACCELERON PHARMA I ...MCLAUGHLIN KEVIN FSVP, CFO and Treasu ...BuyM24.114,00096,44015,21611.2 K to 15.2 K (+35.66 %)
Jan 24 2020XLRNACCELERON PHARMA I ...Smith Karen L.DirectorOption ExerciseA52.998,185433,7238,185
Jan 24 2020XLRNACCELERON PHARMA I ...Smith Karen L.DirectorGrantA0.001,37702,9391.6 K to 2.9 K (+88.16 %)
Jan 24 2020XLRNACCELERON PHARMA I ...Zakrzewski Joseph SDirectorOption ExerciseA52.998,185433,7238,185
Jan 24 2020XLRNACCELERON PHARMA I ...Zakrzewski Joseph SDirectorGrantA0.001,377032,87731.5 K to 32.9 K (+4.37 %)
Jan 24 2020XLRNACCELERON PHARMA I ...MCCOURT Thomas ADirectorOption ExerciseA52.998,185433,7238,185
Jan 24 2020XLRNACCELERON PHARMA I ...MCCOURT Thomas ADirectorGrantA0.001,37704,4223 K to 4.4 K (+45.22 %)
Jan 24 2020XLRNACCELERON PHARMA I ...Kearney Terrence CDirectorOption ExerciseA52.998,185433,7238,185
Jan 24 2020XLRNACCELERON PHARMA I ...Kearney Terrence CDirectorGrantA0.001,37705,1273.8 K to 5.1 K (+36.72 %)
Jan 24 2020XLRNACCELERON PHARMA I ...George JeanDirectorOption ExerciseA52.998,185433,7238,185
Jan 24 2020XLRNACCELERON PHARMA I ...George JeanDirectorGrantA0.001,37705,1273.8 K to 5.1 K (+36.72 %)
Jan 24 2020XLRNACCELERON PHARMA I ...Nader FrancoisDirectorOption ExerciseA52.998,185433,7238,185
Jan 24 2020XLRNACCELERON PHARMA I ...Nader FrancoisDirectorGrantA0.001,37705,1273.8 K to 5.1 K (+36.72 %)
Jan 24 2020XLRNACCELERON PHARMA I ...Veness Adam MVP, General Counsel ...Option ExerciseA52.9924,3341,289,45924,334
Jan 24 2020XLRNACCELERON PHARMA I ...Veness Adam MVP, General Counsel ...GrantA0.006,369021,16114.8 K to 21.2 K (+43.06 %)
Jan 24 2020XLRNACCELERON PHARMA I ...KANGO SUJAYSVP, Chief Commerci ...Option ExerciseA52.9924,3341,289,45924,334
Jan 24 2020XLRNACCELERON PHARMA I ...KANGO SUJAYSVP, Chief Commerci ...GrantA0.006,369015,9399.6 K to 15.9 K (+66.55 %)
Jan 24 2020XLRNACCELERON PHARMA I ...MCLAUGHLIN KEVIN FSVP, CFO and Treasu ...Option ExerciseA52.9924,3341,289,45924,334
Jan 24 2020XLRNACCELERON PHARMA I ...MCLAUGHLIN KEVIN FSVP, CFO and Treasu ...GrantA0.006,369011,2164.8 K to 11.2 K (+131.40 %)
Jan 24 2020XLRNACCELERON PHARMA I ...Dable Habib JCEO and PresidentOption ExerciseA52.9984,7204,489,31384,720
Jan 24 2020XLRNACCELERON PHARMA I ...Dable Habib JCEO and PresidentGrantA0.0022,173089,32467.2 K to 89.3 K (+33.02 %)
Jan 09 2020XLRNACCELERON PHARMA I ...Zakrzewski Joseph SDirectorOption ExerciseM3.8818,75072,7500
Jan 09 2020XLRNACCELERON PHARMA I ...Zakrzewski Joseph SDirectorBuyM3.8818,75072,75031,50012.8 K to 31.5 K (+147.06 %)
Jan 03 2020XLRNACCELERON PHARMA I ...Veness Adam MVP, General Counsel ...SellS51.2387544,82614,79215.7 K to 14.8 K (-5.58 %)
Jan 03 2020XLRNACCELERON PHARMA I ...Veness Adam MVP, General Counsel ...SellS52.8343422,92815,66716.1 K to 15.7 K (-2.70 %)
Jan 03 2020XLRNACCELERON PHARMA I ...KANGO SUJAYSVP, Chief Commerci ...SellS51.27115649,5709.6 K to 9.6 K (-0.11 %)
Jan 03 2020XLRNACCELERON PHARMA I ...KANGO SUJAYSVP, Chief Commerci ...SellS51.3746924,0939,58110.1 K to 9.6 K (-4.67 %)
Jan 03 2020XLRNACCELERON PHARMA I ...Quisel John DEVP, Chief Business ...SellS52.524,242222,79053,31657.6 K to 53.3 K (-7.37 %)
Jan 03 2020XLRNACCELERON PHARMA I ...Quisel John DEVP, Chief Business ...SellS52.511,60084,01657,55859.2 K to 57.6 K (-2.70 %)
Jan 03 2020XLRNACCELERON PHARMA I ...MCLAUGHLIN KEVIN FSVP, CFO and Treasu ...SellS52.521,56682,2464,8476.4 K to 4.8 K (-24.42 %)
Jan 03 2020XLRNACCELERON PHARMA I ...MCLAUGHLIN KEVIN FSVP, CFO and Treasu ...SellS52.492,300120,7276,4138.7 K to 6.4 K (-26.40 %)
Jan 03 2020XLRNACCELERON PHARMA I ...MCLAUGHLIN KEVIN FSVP, CFO and Treasu ...SellS52.511,71389,9508,71310.4 K to 8.7 K (-16.43 %)
Jan 03 2020XLRNACCELERON PHARMA I ...Dable Habib JCEO and PresidentSellS51.243,634186,20667,15170.8 K to 67.2 K (-5.13 %)
Jan 03 2020XLRNACCELERON PHARMA I ...Dable Habib JCEO and PresidentSellS51.26985,02370,78570.9 K to 70.8 K (-0.14 %)
Jan 03 2020XLRNACCELERON PHARMA I ...Backstrom Jay T.EVP, Research and D ...Option ExerciseA52.6194,8654,990,84894,865
Jan 03 2020XLRNACCELERON PHARMA I ...Backstrom Jay T.EVP, Research and D ...GrantA0.0017,107017,1070 to 17.1 K
Jan 03 2020XLRNACCELERON PHARMA I ...Malik KemalDirectorOption ExerciseA52.6117,567924,20017,567
Jan 03 2020XLRNACCELERON PHARMA I ...Veness Adam MVP, General Counsel ...SellS51.2387544,82614,79215.7 K to 14.8 K (-5.58 %)
Jan 03 2020XLRNACCELERON PHARMA I ...Veness Adam MVP, General Counsel ...SellS52.8343422,92815,66716.1 K to 15.7 K (-2.70 %)
Jan 03 2020XLRNACCELERON PHARMA I ...KANGO SUJAYSVP, Chief Commerci ...SellS51.27115649,5709.6 K to 9.6 K (-0.11 %)
Jan 03 2020XLRNACCELERON PHARMA I ...KANGO SUJAYSVP, Chief Commerci ...SellS51.3746924,0939,58110.1 K to 9.6 K (-4.67 %)
Jan 03 2020XLRNACCELERON PHARMA I ...Quisel John DEVP, Chief Business ...SellS52.524,242222,79053,31657.6 K to 53.3 K (-7.37 %)
Jan 03 2020XLRNACCELERON PHARMA I ...Quisel John DEVP, Chief Business ...SellS52.511,60084,01657,55859.2 K to 57.6 K (-2.70 %)
Jan 03 2020XLRNACCELERON PHARMA I ...MCLAUGHLIN KEVIN FSVP, CFO and Treasu ...SellS52.521,56682,2464,8476.4 K to 4.8 K (-24.42 %)
Jan 03 2020XLRNACCELERON PHARMA I ...MCLAUGHLIN KEVIN FSVP, CFO and Treasu ...SellS52.492,300120,7276,4138.7 K to 6.4 K (-26.40 %)
Jan 03 2020XLRNACCELERON PHARMA I ...MCLAUGHLIN KEVIN FSVP, CFO and Treasu ...SellS52.511,71389,9508,71310.4 K to 8.7 K (-16.43 %)
Jan 03 2020XLRNACCELERON PHARMA I ...Dable Habib JCEO and PresidentSellS51.243,634186,20667,15170.8 K to 67.2 K (-5.13 %)
Jan 03 2020XLRNACCELERON PHARMA I ...Dable Habib JCEO and PresidentSellS51.26985,02370,78570.9 K to 70.8 K (-0.14 %)
Jan 03 2020XLRNACCELERON PHARMA I ...Backstrom Jay T.EVP, Research and D ...Option ExerciseA52.6194,8654,990,84894,865
Jan 03 2020XLRNACCELERON PHARMA I ...Backstrom Jay T.EVP, Research and D ...GrantA0.0017,107017,1070 to 17.1 K
Jan 03 2020XLRNACCELERON PHARMA I ...Malik KemalDirectorOption ExerciseA52.6117,567924,20017,567
Dec 17 2019XLRNACCELERON PHARMA I ...MCLAUGHLIN KEVIN FSVP, CFO and Treasu ...SellS50.2811,853595,96910,42622.3 K to 10.4 K (-53.20 %)
Sep 10 2019XLRNACCELERON PHARMA I ...Veness Adam MVP, General Counsel ...SellS45.75231,05216,10116.1 K to 16.1 K (-0.14 %)
Sep 10 2019XLRNACCELERON PHARMA I ...Veness Adam MVP, General Counsel ...SellS45.1880136,18916,12416.9 K to 16.1 K (-4.73 %)
Sep 10 2019XLRNACCELERON PHARMA I ...Veness Adam MVP, General Counsel ...SellS45.75231,05216,10116.1 K to 16.1 K (-0.14 %)
Sep 10 2019XLRNACCELERON PHARMA I ...Kumar RavindraSVP & Chief Scienti ...SellS45.243,389153,31886,98690.4 K to 87 K (-3.75 %)
Sep 10 2019XLRNACCELERON PHARMA I ...Veness Adam MVP, General Counsel ...SellS45.1880136,18916,12416.9 K to 16.1 K (-4.73 %)
Sep 10 2019XLRNACCELERON PHARMA I ...Quisel John DEVP, Chief Business ...SellS45.233,584162,10459,15862.7 K to 59.2 K (-5.71 %)
Sep 10 2019XLRNACCELERON PHARMA I ...Kumar RavindraSVP & Chief Scienti ...SellS45.243,389153,31886,98690.4 K to 87 K (-3.75 %)
Sep 10 2019XLRNACCELERON PHARMA I ...MCLAUGHLIN KEVIN FSVP, CFO and Treasu ...SellS45.751737,91522,27922.5 K to 22.3 K (-0.77 %)
Sep 10 2019XLRNACCELERON PHARMA I ...Quisel John DEVP, Chief Business ...SellS45.233,584162,10459,15862.7 K to 59.2 K (-5.71 %)
Sep 10 2019XLRNACCELERON PHARMA I ...MCLAUGHLIN KEVIN FSVP, CFO and Treasu ...SellS45.297,827354,48522,45230.3 K to 22.5 K (-25.85 %)
Sep 10 2019XLRNACCELERON PHARMA I ...MCLAUGHLIN KEVIN FSVP, CFO and Treasu ...SellS45.751737,91522,27922.5 K to 22.3 K (-0.77 %)
Sep 10 2019XLRNACCELERON PHARMA I ...MCLAUGHLIN KEVIN FSVP, CFO and Treasu ...SellS45.297,827354,48522,45230.3 K to 22.5 K (-25.85 %)
Sep 10 2019XLRNACCELERON PHARMA I ...Dable Habib JCEO and PresidentSellS45.6734415,71070,88371.2 K to 70.9 K (-0.48 %)
Sep 10 2019XLRNACCELERON PHARMA I ...Dable Habib JCEO and PresidentSellS45.205,281238,70171,22776.5 K to 71.2 K (-6.90 %)
Sep 10 2019XLRNACCELERON PHARMA I ...Dable Habib JCEO and PresidentSellS45.6734415,71070,88371.2 K to 70.9 K (-0.48 %)
Sep 10 2019XLRNACCELERON PHARMA I ...Dable Habib JCEO and PresidentSellS45.205,281238,70171,22776.5 K to 71.2 K (-6.90 %)
Aug 12 2019XLRNACCELERON PHARMA I ...Veness Adam MVP, General Counsel ...SellS45.003,268147,06016,92520.2 K to 16.9 K (-16.18 %)
Jul 17 2019XLRNACCELERON PHARMA I ...Veness Adam MVP, General Counsel ...SellS40.7153821,90220,19320.7 K to 20.2 K (-2.60 %)
Jul 11 2019XLRNACCELERON PHARMA I ...Quisel John DEVP, Chief Business ...Option ExerciseM7.121,56211,1210
Jul 11 2019XLRNACCELERON PHARMA I ...Quisel John DEVP, Chief Business ...Option ExerciseM5.282,34612,3870
Jul 11 2019XLRNACCELERON PHARMA I ...Quisel John DEVP, Chief Business ...Option ExerciseM3.885,00019,4000
Jul 11 2019XLRNACCELERON PHARMA I ...Quisel John DEVP, Chief Business ...BuyM7.121,56211,12162,74261.2 K to 62.7 K (+2.55 %)
Jul 11 2019XLRNACCELERON PHARMA I ...Quisel John DEVP, Chief Business ...BuyM5.282,34612,38761,18058.8 K to 61.2 K (+3.99 %)
Jul 11 2019XLRNACCELERON PHARMA I ...Quisel John DEVP, Chief Business ...BuyM3.885,00019,40058,83453.8 K to 58.8 K (+9.29 %)
Jun 28 2019XLRNACCELERON PHARMA I ...George JeanDirectorOption ExerciseM30.177,500226,2750
Jun 28 2019XLRNACCELERON PHARMA I ...George JeanDirectorOption ExerciseM27.9710,000279,7000
Jun 28 2019XLRNACCELERON PHARMA I ...George JeanDirectorOption ExerciseM24.1120,000482,2000
Jun 28 2019XLRNACCELERON PHARMA I ...George JeanDirectorSellS41.1711,812486,300011.8 K to 0 (-100.00 %)
Jun 28 2019XLRNACCELERON PHARMA I ...George JeanDirectorBuyJ0.0011,812011,8120 to 11.8 K
Jun 28 2019XLRNACCELERON PHARMA I ...George JeanDirectorSellJ0.0011,81203,75015.6 K to 3.8 K (-75.90 %)
Jun 28 2019XLRNACCELERON PHARMA I ...George JeanDirectorSellS39.1625,6881,005,94215,56241.3 K to 15.6 K (-62.27 %)
Jun 28 2019XLRNACCELERON PHARMA I ...George JeanDirectorBuyM30.177,500226,27541,25033.8 K to 41.3 K (+22.22 %)
Jun 28 2019XLRNACCELERON PHARMA I ...George JeanDirectorBuyM27.9710,000279,70033,75023.8 K to 33.8 K (+42.11 %)
Jun 28 2019XLRNACCELERON PHARMA I ...George JeanDirectorBuyM24.1120,000482,20023,7503.8 K to 23.8 K (+533.33 %)
Jun 17 2019XLRNACCELERON PHARMA I ...Zakrzewski Joseph SDirectorBuyP38.055,000190,25012,7507.8 K to 12.8 K (+64.52 %)
Jun 07 2019XLRNACCELERON PHARMA I ...Veness Adam MVP, General Counsel ...Option ExerciseA40.376,700270,4796,700
Jun 07 2019XLRNACCELERON PHARMA I ...Veness Adam MVP, General Counsel ...GrantA0.001,100020,73119.6 K to 20.7 K (+5.60 %)
Jun 07 2019XLRNACCELERON PHARMA I ...Veness Adam MVP, General Counsel ...Option ExerciseA40.376,700270,4796,700
Jun 07 2019XLRNACCELERON PHARMA I ...Veness Adam MVP, General Counsel ...GrantA0.001,100020,73119.6 K to 20.7 K (+5.60 %)
Apr 11 2019XLRNACCELERON PHARMA I ...Kumar RavindraSVP & Chief Scienti ...SellS44.24703,09790,37590.4 K to 90.4 K (-0.08 %)
Apr 11 2019XLRNACCELERON PHARMA I ...Kumar RavindraSVP & Chief Scienti ...SellS45.461004,54690,44590.5 K to 90.4 K (-0.11 %)
Apr 11 2019XLRNACCELERON PHARMA I ...Kumar RavindraSVP & Chief Scienti ...SellS44.623,452154,02890,54594 K to 90.5 K (-3.67 %)
Apr 11 2019XLRNACCELERON PHARMA I ...Quisel John DEVP, CBO and Secret ...SellS44.24703,09753,83453.9 K to 53.8 K (-0.13 %)
Apr 11 2019XLRNACCELERON PHARMA I ...Quisel John DEVP, CBO and Secret ...SellS45.461004,54653,90454 K to 53.9 K (-0.19 %)
Apr 11 2019XLRNACCELERON PHARMA I ...Quisel John DEVP, CBO and Secret ...SellS44.623,452154,02854,00457.5 K to 54 K (-6.01 %)
Apr 11 2019XLRNACCELERON PHARMA I ...MCLAUGHLIN KEVIN FSVP, CFO and Treasu ...SellS45.461004,54630,27930.4 K to 30.3 K (-0.33 %)
Apr 11 2019XLRNACCELERON PHARMA I ...MCLAUGHLIN KEVIN FSVP, CFO and Treasu ...SellS44.6111,900530,85930,37942.3 K to 30.4 K (-28.15 %)
Apr 11 2019XLRNACCELERON PHARMA I ...Dable Habib JCEO and PresidentSellS44.231466,45876,50876.7 K to 76.5 K (-0.19 %)
Apr 11 2019XLRNACCELERON PHARMA I ...Dable Habib JCEO and PresidentSellS45.461004,54676,65476.8 K to 76.7 K (-0.13 %)
Apr 11 2019XLRNACCELERON PHARMA I ...Dable Habib JCEO and PresidentSellS44.607,214321,74476,75484 K to 76.8 K (-8.59 %)
Apr 04 2019XLRNACCELERON PHARMA I ...MCLAUGHLIN KEVIN FSVP, CFO and Treasu ...SellS48.0264831,11742,27942.9 K to 42.3 K (-1.51 %)
Jan 29 2019XLRNACCELERON PHARMA I ...Zakrzewski Joseph SDirectorOption ExerciseA41.647,500312,3007,500
Jan 29 2019XLRNACCELERON PHARMA I ...Zakrzewski Joseph SDirectorGrantA0.001,25007,7506.5 K to 7.8 K (+19.23 %)
Jan 29 2019XLRNACCELERON PHARMA I ...Smith Karen L.DirectorOption ExerciseA41.647,500312,3007,500
Jan 29 2019XLRNACCELERON PHARMA I ...Smith Karen L.DirectorGrantA0.001,25001,562312 to 1.6 K (+400.64 %)
Jan 29 2019XLRNACCELERON PHARMA I ...POPS RICHARD FDirectorOption ExerciseA41.647,500312,3007,500
Jan 29 2019XLRNACCELERON PHARMA I ...POPS RICHARD FDirectorGrantA0.001,250032,50031.3 K to 32.5 K (+4.00 %)
Jan 29 2019XLRNACCELERON PHARMA I ...MCCOURT Thomas ADirectorOption ExerciseA41.647,500312,3007,500
Jan 29 2019XLRNACCELERON PHARMA I ...MCCOURT Thomas ADirectorGrantA0.001,25003,0451.8 K to 3 K (+69.64 %)
Jan 29 2019XLRNACCELERON PHARMA I ...Maniatis TomDirectorOption ExerciseA41.647,500312,3007,500
Jan 29 2019XLRNACCELERON PHARMA I ...Maniatis TomDirectorGrantA0.001,2500136,731135.5 K to 136.7 K (+0.92 %)
Jan 29 2019XLRNACCELERON PHARMA I ...Kearney Terrence CDirectorOption ExerciseA41.647,500312,3007,500
Jan 29 2019XLRNACCELERON PHARMA I ...Kearney Terrence CDirectorGrantA0.001,25003,7502.5 K to 3.8 K (+50.00 %)
Jan 29 2019XLRNACCELERON PHARMA I ...George JeanDirectorOption ExerciseA41.647,500312,3007,500
Jan 29 2019XLRNACCELERON PHARMA I ...George JeanDirectorGrantA0.001,25003,7502.5 K to 3.8 K (+50.00 %)
Jan 29 2019XLRNACCELERON PHARMA I ...Nader FrancoisDirectorOption ExerciseA41.647,500312,3007,500
Jan 29 2019XLRNACCELERON PHARMA I ...Nader FrancoisDirectorGrantA0.001,25003,7502.5 K to 3.8 K (+50.00 %)
Jan 29 2019XLRNACCELERON PHARMA I ...Kumar RavindraSVP & Chief Scienti ...Option ExerciseA41.6421,500895,26021,500

Page:   < prev 1 2 3 4 5 6 ... 11 next >

Contact us | Follow us on Twitter